疾病预防控制中心167显示出作为喘呼吸道炎症生物标志物的潜力
Yukai Zhong1, Qiong Wu2, Li Cai3
1Department of Pediatrics, Kongjiang Hospital of Shanghai Yangpu District, Shanghai, 200093, China.
概括
这项研究确定了CDC167作为潜在的诊断标记物和喘治疗点. 在小鼠中沉默CDC167减少了炎症和肺损伤,突出了其在喘进展中的作用.
科学领域:
- 肺部医学 肺部医学
- 遗传学 是一个遗传学.
- 生物信息学是一种生物信息学.
背景情况:
- 喘是一种慢性呼吸道疾病,治疗选择有限.
- 目前的治疗方法旨在控制症状并减缓疾病的进展.
- 新的治疗目标对于改善喘管理至关重要.
研究的目的:
- 识别和描述喘的新型治疗点.
- 为了研究特定基因在喘发病过程中的作用.
- 验证潜在的喘诊断标志物和治疗策略.
主要方法:
- 对喘数据集的基因表达差异分析 (GSE64913,GSE137268).
- 权重基因关联网络分析 (WGCNA) 用于识别与喘相关的基因模块.
- 机器学习算法 (LASSO,随机森林,SVM) 用于候选基因选.
- 对基因表达,诊断价值和途径的生物信息分析.
- 在卵胺诱导的喘小鼠模型中的候选基因体内验证.
主要成果:
- 确定了1710个差异表达基因 (DEG) 和2367个喘模块基因.
- 通过综合分析选择了四个候选基因 (CDC167,POSTN,SEC14L1,SERPINB2).
- 所有候选基因在喘患者中都被上调,并显示出诊断效用.
- 在喘小鼠中沉默CDC167显著降低了炎症性细胞因子和肺损伤.
结论:
- CDC167是一种有前途的喘诊断标志物.
- CDC167代表了喘治疗的潜在治疗标.
- 对CDC167作用的进一步研究可能会导致新的喘疗法.
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:20Asthma: Pathogenesis and Management
391
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
391
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
284
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
284
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K